Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer (Q39527898)

12 September 2017

Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer (English)

1 reference

12 September 2017

Clostridium perfringens

object named as

Clostridium perfringens

1 reference

1 reference

7

Naoya Masumori

1 reference

12 September 2017

6

Takashi Kojima

1 reference

12 September 2017

8

Taiji Tsukamoto

1 reference

12 September 2017

Toshihiro Maeda

1

1 reference

12 September 2017

Masaki Murata

2

1 reference

12 September 2017

Hideki Chiba

3

1 reference

12 September 2017

Akira Takasawa

4

1 reference

12 September 2017

Satoshi Tanaka

5

1 reference

12 September 2017

Norimasa Sawada

9

1 reference

12 September 2017

8 June 2011

1 reference

12 September 2017

1 reference

12 September 2017

72

1 reference

12 September 2017

4

1 reference

12 September 2017

351-360

1 reference

12 September 2017

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21436

Therapeutic options for hormone-refractory prostate cancer in 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21436

Multifunctional strands in tight junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21436

Restoration of tight junction structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21436

Oncogenic Raf-1 disrupts epithelial tight junctions via downregulation of occludin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21436

Increased tight junctional permeability is associated with the development of colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21436

Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21436

Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21436

Barriers built on claudins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21436

Claudins in occluding junctions of humans and flies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21436

Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21436

Claudin proteins in human cancer: promising new targets for diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21436

Claudins: emerging targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21436

Claudins: multifunctional players in epithelial tight junctions and their role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21436

Molecular cloning and functional characterization of the receptor for Clostridium perfringens enterotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21436

Identification of a prepore large-complex stage in the mechanism of action of Clostridium perfringens enterotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21436

Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21436

Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21436

Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21436

Overexpression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in uterine carcinosarcomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21436

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21436

Molecular determinants of the interaction between Clostridium perfringens enterotoxin fragments and claudin-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21436

Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: Evidence for direct involvement of claudins in tight junction barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21436

Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21436

21 January 2018

Identifiers

DOI

10.1002/PROS.21436

1 reference

12 September 2017

1 reference